1wth: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
|PDB= 1wth |SIZE=350|CAPTION= <scene name='initialview01'>1wth</scene>, resolution 2.80Å | |PDB= 1wth |SIZE=350|CAPTION= <scene name='initialview01'>1wth</scene>, resolution 2.80Å | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand=K:POTASSIUM+ION'>K</scene> | |LIGAND= <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene> | ||
|ACTIVITY= [http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span> | ||
|GENE= 5 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id= | |GENE= 5 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10665 Enterobacteria phage T4]), 27 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10665 Enterobacteria phage T4]) | ||
|DOMAIN= | |||
|RELATEDENTRY=[[1k28|1K28]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1wth FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1wth OCA], [http://www.ebi.ac.uk/pdbsum/1wth PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1wth RCSB]</span> | |||
}} | }} | ||
| Line 16: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
1WTH is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ | 1WTH is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Enterobacteria_phage_t4 Enterobacteria phage t4]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1WTH OCA]. | ||
==Reference== | ==Reference== | ||
Control of bacteriophage T4 tail lysozyme activity during the infection process., Kanamaru S, Ishiwata Y, Suzuki T, Rossmann MG, Arisaka F, J Mol Biol. 2005 Mar 4;346(4):1013-20. Epub 2005 Jan 25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15701513 15701513] | Control of bacteriophage T4 tail lysozyme activity during the infection process., Kanamaru S, Ishiwata Y, Suzuki T, Rossmann MG, Arisaka F, J Mol Biol. 2005 Mar 4;346(4):1013-20. Epub 2005 Jan 25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15701513 15701513] | ||
[[Category: | [[Category: Enterobacteria phage t4]] | ||
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
| Line 28: | Line 31: | ||
[[Category: Rossmann, M G.]] | [[Category: Rossmann, M G.]] | ||
[[Category: Suzuki, T.]] | [[Category: Suzuki, T.]] | ||
[[Category: gp5-gp27]] | [[Category: gp5-gp27]] | ||
[[Category: hub]] | [[Category: hub]] | ||
| Line 37: | Line 38: | ||
[[Category: triple-stranded beta-helix]] | [[Category: triple-stranded beta-helix]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 00:40:48 2008'' | ||
Revision as of 00:40, 31 March 2008
| |||||||
| , resolution 2.80Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | , | ||||||
| Gene: | 5 (Enterobacteria phage T4), 27 (Enterobacteria phage T4) | ||||||
| Activity: | Lysozyme, with EC number 3.2.1.17 | ||||||
| Related: | 1K28
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Crystal structure of gp5-S351L mutant and gp27 complex
OverviewOverview
Bacteriophage T4 has an efficient mechanism for injecting the host Escherichiacoli cell with genomic DNA. Its gene product 5 (gp5) has a needle-like structure attached to the end of a tube through which the DNA passes on its way out of the head and into the host. The gp5 needle punctures the outer cell membrane and then digests the peptidoglycan cell wall in the periplasmic space. gp5 is normally post-translationally cleaved between residues 351 and 352. The function of this process in controlling the lysozyme activity of gp5 has now been investigated. When gp5 is over-expressed in E.coli, two mutants (S351H and S351A) showed a reduction of cleavage products and five other mutants (S351L, S351K, S351Y, S351Q, and S351T) showed no cleavage. Furthermore, in a complementation assay at 20 degrees C, the mutants that had no cleavage of gp5 produced a reduced number of plaques compared to wild-type T4. The crystal structure of the non-cleavage phenotype mutant of gp5, S351L, complexed with gene product 27, showed that the 18 residues in the vicinity of the potential cleavage site (disordered in the wild-type structure) had visible electron density. The polypeptide around the potential cleavage site is exposed, thus allowing access for an E.coli protease. The lysozyme activity is inhibited in the wild-type structure by a loop from the adjacent gp5 monomer that binds into the substrate-binding site. The same inhibition is apparent in the mutant structure, showing that the lysozyme is inhibited before gp5 is cleaved and, presumably, the lysozyme is activated only after gp5 has penetrated the outer membrane.
About this StructureAbout this Structure
1WTH is a Protein complex structure of sequences from Enterobacteria phage t4. Full crystallographic information is available from OCA.
ReferenceReference
Control of bacteriophage T4 tail lysozyme activity during the infection process., Kanamaru S, Ishiwata Y, Suzuki T, Rossmann MG, Arisaka F, J Mol Biol. 2005 Mar 4;346(4):1013-20. Epub 2005 Jan 25. PMID:15701513
Page seeded by OCA on Mon Mar 31 00:40:48 2008